Victoria L Seewaldt
City of Hope Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Victoria L Seewaldt as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:23 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06763328 · Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing ChemotherapyCity of Hope Medical Center · recruiting · Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 · principal investigator
- N/ANCT05414396 · Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved CommunitiesCity of Hope Medical Center · active not recruiting · Diabetes Mellitus, Obesity-Related Malignant Neoplasm · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 12 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 1/2 Drug Development and Capacity Building: A UCR/CoH-CCC PartnershipU54CA285116 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2023 to 2026 · $1,380,456 awarded in 2026Grant number is on one of their registry trials
- Cancer Metabolism Training ProgramT32CA221709 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2018 to 2026 · $236,201 awarded in 2026Same name and institution; not confirmed by an ID
- Population Facing ResearchP30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2023 to 2026 · $222,902 awarded in 2026Grant number is on one of their registry trials
- Admin-CoreP20CA242619 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2019 to 2022 · $178,131 awarded in 2022Same name and institution; not confirmed by an ID
- Epigenetic damage in women living in LA food-desert zip codesR01CA220693 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2017 to 2021 · $700,381 awarded in 2021Same name and institution; not confirmed by an ID
- Combined breast MRI/biomarker strategies to identify aggressive biologyU01CA189283 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2015 to 2020 · $649,862 awarded in 2020Same name and institution; not confirmed by an ID
- Targeted Chemoprevention of Breast Cancer: From the Bench to Clinical TestingR01CA158668 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2012 to 2016 · $335,466 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:23 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial.Support Care Cancer · 2009186 citationsRCR 6.4
- Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration.Cancer Epidemiol Biomarkers Prev · 200539 citationsRCR 0.8
- A Co-clinical Trial of Exercise Therapy in Breast Cancer Prevention.Clin Cancer Res · 20252 citationsRCR 0.4